GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Foundation Medicine Inc (NAS:FMI) » Definitions » Asset Turnover

Foundation Medicine (Foundation Medicine) Asset Turnover : 0.31 (As of Jun. 2018)


View and export this data going back to 2013. Start your Free Trial

What is Foundation Medicine Asset Turnover?

Asset Turnover measures how quickly a company turns over its asset through sales. It is calculated as Revenue divided by Total Assets. Foundation Medicine's Revenue for the three months ended in Jun. 2018 was $57.0 Mil. Foundation Medicine's Total Assets for the quarter that ended in Jun. 2018 was $185.3 Mil. Therefore, Foundation Medicine's Asset Turnover for the quarter that ended in Jun. 2018 was 0.31.

Asset Turnover is linked to ROE % through Du Pont Formula. Foundation Medicine's annualized ROE % for the quarter that ended in Jun. 2018 was -2,577.53%. It is also linked to ROA % through Du Pont Formula. Foundation Medicine's annualized ROA % for the quarter that ended in Jun. 2018 was -72.05%.


Foundation Medicine Asset Turnover Historical Data

The historical data trend for Foundation Medicine's Asset Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Foundation Medicine Asset Turnover Chart

Foundation Medicine Annual Data
Trend Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17
Asset Turnover
Get a 7-Day Free Trial 0.26 0.45 0.46 0.46 0.80

Foundation Medicine Quarterly Data
Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18
Asset Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.22 0.29 0.31 0.31 0.31

Competitive Comparison of Foundation Medicine's Asset Turnover

For the Diagnostics & Research subindustry, Foundation Medicine's Asset Turnover, along with its competitors' market caps and Asset Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Foundation Medicine's Asset Turnover Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Foundation Medicine's Asset Turnover distribution charts can be found below:

* The bar in red indicates where Foundation Medicine's Asset Turnover falls into.



Foundation Medicine Asset Turnover Calculation

Asset Turnover measures how quickly a company turns over its asset through sales.

Foundation Medicine's Asset Turnover for the fiscal year that ended in Dec. 2017 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (A: Dec. 2017 )/( (Total Assets (A: Dec. 2016 )+Total Assets (A: Dec. 2017 ))/ count )
=152.903/( (214.035+169.003)/ 2 )
=152.903/191.519
=0.80

Foundation Medicine's Asset Turnover for the quarter that ended in Jun. 2018 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (Q: Jun. 2018 )/( (Total Assets (Q: Mar. 2018 )+Total Assets (Q: Jun. 2018 ))/ count )
=57.006/( (177.165+193.44)/ 2 )
=57.006/185.3025
=0.31

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies with low profit margins tend to have high Asset Turnover, while those with high profit margins have low Asset Turnover. Companies in the retail industry tend to have a very high turnover ratio.


Foundation Medicine  (NAS:FMI) Asset Turnover Explanation

Asset Turnover is linked to ROE % through Du Pont Formula.

Foundation Medicine's annulized ROE % for the quarter that ended in Jun. 2018 is

ROE %**(Q: Jun. 2018 )
=Net Income/Total Stockholders Equity
=-133.516/5.18
=(Net Income / Revenue)*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(-133.516 / 228.024)*(228.024 / 185.3025)*(185.3025/ 5.18)
=Net Margin %*Asset Turnover*Equity Multiplier
=-58.55 %*1.2306*35.7727
=ROA %*Equity Multiplier
=-72.05 %*35.7727
=-2,577.53 %

Note: The Net Income data used here is four times the quarterly (Jun. 2018) net income data. The Revenue data used here is four times the quarterly (Jun. 2018) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** The ROE % used above is for Du Pont Analysis only. It is different from the defined ROE % page on our website, as here it uses Net Income instead of Net Income attributable to Common Stockholders in the calculation.

It is also linked to ROA % through Du Pont Formula:

Foundation Medicine's annulized ROA % for the quarter that ended in Jun. 2018 is

ROA %(Q: Jun. 2018 )
=Net Income/Total Assets
=-133.516/185.3025
=(Net Income / Revenue)*(Revenue / Total Assets)
=(-133.516 / 228.024)*(228.024 / 185.3025)
=Net Margin %*Asset Turnover
=-58.55 %*1.2306
=-72.05 %

Note: The Net Income data used here is four times the quarterly (Jun. 2018) net income data. The Revenue data used here is four times the quarterly (Jun. 2018) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Therefore, it is a good sign if a company's Asset Turnover is consistent or even increases. If a company's asset grows faster than sales, its Asset Turnover will decline, which can be a warning sign.


Foundation Medicine Asset Turnover Related Terms

Thank you for viewing the detailed overview of Foundation Medicine's Asset Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.


Foundation Medicine (Foundation Medicine) Business Description

Traded in Other Exchanges
N/A
Address
Foundation Medicine Inc is a molecular diagnostics company that specializes in the evaluation and treatment of cancer. Its products provide genetic information about a patient's cancer that is used by physicians to inform clinical decisions and by biopharmaceutical companies to develop targeted oncology therapies. Foundation Medicine's core molecular information products include FoundationOne, for solid tumors, and FoundationOne Heme, for blood-based cancers and hematologic malignancies. The vast majority of the firm's revenue is generated within the United States.
Executives
Alexis Borisy director C/O COMBINATORX, INCORPORATED, 245 FIRST STREET, 16TH FLOOR, CAMBRIDGE MA 02142
Vincent A. Miller officer: Chief Medical Officer C/O FOUNDATION MEDICINE, INC., ONE KENDALL SQUARE, SUITE B3501, CAMBRIDGE MA 02139
Michael J Pellini director 222 DUTTON MILL RD, WILLISTOWN PA 19380
Jason Ryan officer: Chief Financial Officer C/O FOUNDATION MEDICINE, INC., ONE KENDALL SQUARE, SUITE B3501, CAMBRIDGE MA 02139
Troy Cox director, officer: President and CEO C/O FOUNDATION MEDICINE, INC., C/O FOUNDATION MEDICINE, INC., 150 SECON, CAMBRIDGE MA 02141
Robert W. Hesslein officer: SVP and General Counsel C/O FOUNDATION MEDICINE, INC., ONE KENDALL SQUARE, SUITE B3501, CAMBRIDGE MA 02139
Thomas Civik officer: Chief Commercial Officer C/O FOUNDATION MEDICINE, INC., 150 SECOND STREET, CAMBRIDGE MA 02141
Evan/ Fa Jones director C/O OPGEN, INC., 708 QUINCE ORCHARD ROAD, SUITE 205, GAITHERSBURG MD 20878
Michael R Dougherty director C/O ADOLOR CORP, 700 PENNSYLVANIA DR, EXTON PA 19341
Roche Finance Ltd director, 10 percent owner, other: See footnote (1) C/O HOFFMAN LA ROCHE, 124 GRENSACHERSTRASSE CH 4002, BASEL SWITZERLAND V8
Roche Holding Ltd director, 10 percent owner, other: See footnote (1) ROCHE HOLDING, LTD., GRENZACHERSTRASSE 124, BASEL V8 CH-4070
David P Schenkein director C/O BLUEBIRD BIO, INC., 840 MEMORIAL DRIVE, CAMBRIDGE MA 02139
Robert I Tepper 10 percent owner 201 BROOKLINE AVE, SUITE 1401, BOSTON MA 02215
Mark J Levin 10 percent owner 29 NEWBURY STREET, 3RD FLOOR, BOSTON MA 02116
Third Rock Ventures Gp, L.p. 10 percent owner C/O THIRD ROCK VENTURES, 29 NEWBURY STREET, 3RD FLOOR, BOSTON MA 02116